Valentin Buchter

Multidisciplinary Preclinical Investigations on Three Oxamniquine Analogues as Novel Treatment Options for Schistosomiasis

J. Keiser, U. Rothlisberger, G. Gasser, 2020 .

Assessment of tegumental damage to Schistosoma mansoni and S. haematobium after in vitro exposure to ferrocenyl, ruthenocenyl and benzyl derivatives of oxamniquine using scanning electron microscopy

J. Keiser, G. Gasser, Jeannine Hess, 2018, Parasites & Vectors.

Characterization of moxidectin against Strongyloides ratti: in vitro and in vivo activity and pharmacokinetics in the rat model.

J. Keiser, D. Hofmann, Cécile Häberli, 2020, ACS infectious diseases.

Multidisciplinary Preclinical Investigations on Three Oxamniquine Analogues as Novel Drug Candidates for Schistosomiasis.

J. Keiser, U. Rothlisberger, G. Gasser, 2020, Chemistry.

Validation of a human-serum-based in vitro growth method for drug screening on juvenile development stages of Schistosoma mansoni

J. Keiser, P. H. Schneeberger, Valentin Buchter, 2021, PLoS neglected tropical diseases.

Evolution of COVID-19 mortality over time: results from the Swiss hospital surveillance system (CH-SUR)

M. Roelens, M. Battegay, T. Riedel, 2021, medRxiv.

Preparation, Physicochemical Characterization and In Vitro and In Vivo Activity Against Heligmosomoides polygyrus of Novel Oral Formulations of Albendazole and Mebendazole

J. Keiser, M. Lamas, D. Leonardi, 2020, Journal of Pharmaceutical Sciences.

Activity of novel oral formulations of albendazole and mebendazole against Heligmosomoides polygyrus in vitro and in vivo.

J. Keiser, M. Lamas, D. Leonardi, 2020, Journal of pharmaceutical sciences.